Alzheimer's Association campaigns for broader Leqembi coverage: report

Alzheimer's Association campaigns for broader Leqembi coverage: report

After CMS slapped down a petition for wider coverage of Eisai and Biogen’s new drug Leqembi, the Alzheimer’s Association is digging its heels in.